New EU notification rules kick in for voluntary withdrawal of drugs for safety reasons
This article was originally published in SRA
Executive Summary
Sponsors of drugs evaluated through the centralized procedure in the EU now have to tell the European Medicines Agency if, for safety reasons, they decide to temporarily or permanently suspend the marketing of a drug, withdraw a drug from the market, request withdrawal of a marketing authorization or not renew a marketing authorization1.